Evidence map›Paper›PMID 42636373›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

HLA class I escape drives the evolution of SARS-CoV-2 in human populations.

Ekaterina D Riumina, Evgeniia I Alekseeva, Galya V Klink, Stepan Feigin, Iaroslava Vinogradova, Natalia Ivanova, Dmitry Dianov, Ksenia Zornikova, Vassa Davydova, Apollinariya Bogolyubova and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The other immune landscape of SARS-CoV-2 evolution.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ekaterina D Riumina *Independent researcher.ORCID 0009-0001-2609-8750
Evgeniia I Alekseeva *Independent researcher.ORCID 0000-0002-4510-559X
Galya V Klink *International Laboratory of Statistical and Computational Genomics, Faculty of Computer Science, National Research University Higher School of Economics University, Moscow 109028, Russia.ORCID 0000-0001-8466-6958
Stepan FeiginFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119234, Russia.
Iaroslava VinogradovaCentral University, Moscow 123056, Russia.
Natalia IvanovaLaboratory of Translational Immunology, National Medical Research Center for Hematology, Moscow 125167, Russia.
Dmitry DianovLaboratory of Translational Immunology, National Medical Research Center for Hematology, Moscow 125167, Russia.
Ksenia ZornikovaLaboratory of Translational Immunology, National Medical Research Center for Hematology, Moscow 125167, Russia.
Vassa DavydovaLaboratory of Translational Immunology, National Medical Research Center for Hematology, Moscow 125167, Russia.ORCID 0009-0005-9983-3225
Apollinariya BogolyubovaLaboratory of Translational Immunology, National Medical Research Center for Hematology, Moscow 125167, Russia.
Georgii A BazykinRussian Academy of Sciences, Moscow 119991, Russia.ORCID 0000-0003-2334-2751

Funding

HSE University HSE-BR-2025-020
6 · The paper itself

Abstract

The role of escape from the cytotoxic T cell (CTL) response in Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) evolution remains controversial. Here, we study the origin and spread of SARS-CoV-2 variants whose mutations reduce presentation by the human leukocyte antigen (HLA) class I alleles common in human populations. We find that 35% of mutations that are characteristic of the variants of concern, and 39% of all subsequent viral mutations, facilitate escape of viral epitopes from presentation. Mutations allowing escape from more common HLA alleles reach higher frequencies, particularly in those countries where these HLA alleles are more frequent, indicating that escape is selected by the local genetic composition of the human host population. We also show that viral mutations that accumulated in general-population transmission chains matched population HLA class I allele frequencies as well as, or better than, mutations acquired during persistent infections, suggesting that selection in favor of escape mutations is not limited to immunocompromised individuals. Together, these data reveal CTL escape as a facet of selection, a driver of evolution, and an epidemiological concern for SARS-CoV-2.

Indexed as

Evolution, MolecularHistocompatibility Antigens Class IImmune EvasionSARS-CoV-2COVID-19Gene FrequencyHumansMutationT-Lymphocytes, CytotoxicHistocompatibility Antigens Class IepidemiologyHLASARS-CoV-2T cell escapeviral evolution

Identifiers

PMID42636373
PMCPMC13534678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.